Showing results (61-70 of 177) with videos related to

Sort By:
Pageof 18
Cancer|June 11, 2005
Ovarian carcinoma screening in women at intermediate risk: impact on quality of life and need for invasive follow-upNoah D Kauff, Karen E Hurley, Martee L Hensley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2003
Fallopian tube and primary peritoneal carcinomas associated with BRCA mutationsDouglas A Levine, Peter A Argenta, Cindy J Yee, et al.
Gynecologic Oncology|June 10, 2017
Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White PaperLeslie M Randall, Bhavana Pothuri, Elizabeth M Swisher, et al.
European Journal of Cancer (Oxford, England : 1990)|July 16, 2018
A phase IIA trial of acupuncture to reduce chemotherapy-induced peripheral neuropathy severity during neoadjuvant or adjuvant weekly paclitaxel chemotherapy in breast cancer patientsTing Bao, Andrew D Seidman, Lauren Piulson, et al.
Cancer|May 21, 2011
Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancerZsofia K Stadler, Erin Salo-Mullen, Sujata M Patil, et al.
Plos One|May 4, 2010
Genetic analysis of the early natural history of epithelial ovarian carcinomaBhavana Pothuri, Mario M Leitao, Douglas A Levine, et al.
The New England Journal of Medicine|May 25, 2002
Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutationNoah D Kauff, Jaya M Satagopan, Mark E Robson, et al.
The American Journal of Surgical Pathology|June 11, 2021
PD-L1 Expression in Metaplastic Breast Carcinoma Using the PD-L1 SP142 Assay and Concordance Among PD-L1 Immunohistochemical AssaysAnne Grabenstetter, Achim A Jungbluth, Denise Frosina, et al.
The Oncologist|September 22, 2011
An emerging entity: pancreatic adenocarcinoma associated with a known BRCA mutation: clinical descriptors, treatment implications, and future directionsMaeve A Lowery, David P Kelsen, Zsofia K Stadler, et al.
Breast Cancer Research and Treatment|February 3, 2017
Psychosocial factors associated with the uptake of contralateral prophylactic mastectomy among BRCA1/2 mutation noncarriers with newly diagnosed breast cancerJada G Hamilton, Margaux C Genoff, Melissa Salerno, et al.
Pageof 18